{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:55:01Z","timestamp":1785041701007,"version":"3.55.0"},"reference-count":48,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jccm-2021-0002_s_006\">\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>An increasing trend of cancer associated stroke has been noticed in the past decade.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jccm-2021-0002_s_007\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the risk factors and the incidence of neoplasia in stroke patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jccm-2021-0002_s_008\">\n                  <jats:title>Material and Method<\/jats:title>\n                  <jats:p>A retrospective, observational study was undertaken on 249 patients with stroke and active cancer (SAC) and 1563 patients with stroke without cancer (SWC). The general cardiovascular risk factors, the site of cancer, and the general clinical data were registered and evaluated. According to the \u201cOxfordshire Community Stroke Project\u201d (OCSP) classification, all patients were classified into the clinical subtypes of stroke. The aetiology of stroke was considered as large-artery atherosclerosis, small vessel disease, cardio-embolic, cryptogenic or other determined cause.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jccm-2021-0002_s_009\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The severity of neurological deficits at admission were significantly higher in the SAC group (p&lt;0.01). The haemoglobin level was significantly lower, and platelet level and erythrocyte sedimentation rate were significantly higher in the SAC group. Glycaemia, cholesterol and triglycerides levels were significantly higher in the SWC group. The personal history of hypertension was more frequent in the SWC group. In the SAC group, 28.9% had a cryptogenic aetiology, compared to 9.1% in SWC group. Cardio-embolic strokes were more frequent in the SAC group (24%) than the SWC group (19.6%). In the SAC group, 15,6% were diagnosed with cancer during the stroke hospitalization, and 78% of the SAC patients were without metastasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jccm-2021-0002_s_010\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The most frequent aetiologies of stroke in cancer patients were cryptogenic stroke, followed by large-artery atherosclerosis. SAC patients had more severe neurological deficits and worse clinical outcomes than SWC patients. Stroke in cancer patients appears to be more frequently cryptogenic, probably due to cancer associated thrombosis. The association between stroke and cancer is important, especially in stroke of cryptogenic mechanism, even in the presence of traditional cardiovascular risk factors.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2478\/jccm-2021-0002","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T05:49:39Z","timestamp":1617774579000},"page":"54-61","source":"Crossref","is-referenced-by-count":9,"title":["Ischemic Stroke in Patients with Cancer: A Retrospective Cross-Sectional Study"],"prefix":"10.2478","volume":"7","author":[{"given":"Anca","family":"Motataianu","sequence":"first","affiliation":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaranda","family":"Maier","sequence":"additional","affiliation":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Andone","sequence":"additional","affiliation":[{"name":"Emergency County Hospital Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Barcutean","sequence":"additional","affiliation":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana","family":"Serban","sequence":"additional","affiliation":[{"name":"Emergency County Hospital Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Bajko","sequence":"additional","affiliation":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Balasa","sequence":"additional","affiliation":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"2024043016334229728_j_jccm-2021-0002_ref_001","doi-asserted-by":"crossref","unstructured":"Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau\u2019s syndrome revisited. Blood. 1983;62:1431.","DOI":"10.1182\/blood.V62.1.14.bloodjournal62114"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_002","doi-asserted-by":"crossref","unstructured":"Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine. 1985; 64:16-35.","DOI":"10.1097\/00005792-198501000-00002"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_003","doi-asserted-by":"crossref","unstructured":"Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and aetiology. Neurology. 2004;65: 2025-30.","DOI":"10.1212\/01.WNL.0000129912.56486.2B"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_004","doi-asserted-by":"crossref","unstructured":"Navi BB, Reiner AS, Kamel H, et al. association between incident cancer and subsequent stroke. Ann Neurol.2015;77:291-300.","DOI":"10.1002\/ana.24325"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_005","doi-asserted-by":"crossref","unstructured":"Navi BB, Iadecola C. Ischemic stroke in cancer patients: a review of an underappreciated pathology. Ann Neurol. 2018;83: 873-83.","DOI":"10.1002\/ana.25227"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_006","doi-asserted-by":"crossref","unstructured":"Schwarzbach CJ, Schaefer A, Ebert A, et al. stroke and cancerthe importance of cancer-associated hypercoagulation as a possible stroke aetiology. Stroke.2012;43:3029-34.","DOI":"10.1161\/STROKEAHA.112.658625"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_007","doi-asserted-by":"crossref","unstructured":"Henley SJ, Singh SD, King J, Wilson RJ, O\u2019Neil ME, Ryerson AB. Invasive cancer incidence and survival -United States, 2012. Morb Mortal Wkly Rep. 2015; 64:1353-58.","DOI":"10.15585\/mmwr.mm6449a1"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_008","doi-asserted-by":"crossref","unstructured":"Kneihsl M, Enzinger C, Wunsch G, et al. Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol. 2016; 263:150-56.","DOI":"10.1007\/s00415-015-7954-6"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_009","doi-asserted-by":"crossref","unstructured":"Taccone FS, Jeangette SM, Blecic SA. First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis. 2008;17: 169-74.","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.01.007"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_010","doi-asserted-by":"crossref","unstructured":"Bhattacharjee M, Vairale J, Gawali K, Dalal PM. Factors affecting burden on caregivers of stroke survivors: Population-based study in Mumbai (India). Ann Indian Acad Neurol. 2012;15:113\u2013119.","DOI":"10.4103\/0972-2327.94994"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_011","doi-asserted-by":"crossref","unstructured":"Stefan O, Vera N, Otto B, Heinz L,Wolfgang G. Stroke in cancer patients: a risk factor analysis. J Neurooncol.2009;94:221-26.","DOI":"10.1007\/s11060-009-9818-3"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_012","unstructured":"Balasa A, Chinezu R, Teleanu DM, Pascanu MI, Chinezu L, Borda A. Ectopic intracavernous corticotroph microadenoma: case report of an extremely rare pathology. Rom J Morphol Embryol. 2017;58:1447-1451."},{"key":"2024043016334229728_j_jccm-2021-0002_ref_013","doi-asserted-by":"crossref","unstructured":"Edwardson DW, Boudreau J, Mapletoft J, Lanner C, Kovala AT, Parissenti AM. Inflammatory cytokine production in tumour cells upon chemotherapy drug exposure or upon selection for drug resistance. PLoS One. 2017;12(9):e0183662.","DOI":"10.1371\/journal.pone.0183662"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_014","doi-asserted-by":"crossref","unstructured":"Bamford J, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-1986 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988;51:1373-80.","DOI":"10.1136\/jnnp.51.11.1373"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_015","doi-asserted-by":"crossref","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, et al. classification of subtype of acute ischemic stroke. Definitions for use in multicenter clinical trials. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke.1993;24:35-41.","DOI":"10.1161\/01.STR.24.1.35"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_016","doi-asserted-by":"crossref","unstructured":"Jang H-S, Choi J, Shin J, et al. The long-term effect of cancer on incident stroke: a nationwide population-based cohort study in Korea. Front Neurol.2019;10:52.","DOI":"10.3389\/fneur.2019.00052"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_017","doi-asserted-by":"crossref","unstructured":"Lee MJ, Chung JW, Ahn MJ, et al. Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: The OASIS-CANCER Study. J Stroke. 2017;19(1):77\u201387.","DOI":"10.5853\/jos.2016.00570"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_018","doi-asserted-by":"crossref","unstructured":"Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol. 2006;24(3):484-90.","DOI":"10.1200\/JCO.2005.03.8877"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_019","doi-asserted-by":"crossref","unstructured":"Selvik HA, Thomassen L, Bjerkreim AT, Naess H. Cancer-associated stroke: the Bergen NORSTROKE Study. Cerebrovasc Dis Extra.2015;5:107-113.","DOI":"10.1159\/000440730"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_020","doi-asserted-by":"crossref","unstructured":"Dammacco F, Vacca A, Procaccio P, Ria R, Marech I, Racanelli V. Cancer-related coagulopathy: a review of literature and experience of a single centre of internal medicine. Clin Exp Med 2013;13:85-97.","DOI":"10.1007\/s10238-013-0230-0"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_021","doi-asserted-by":"crossref","unstructured":"Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia.2002;4:465-73.","DOI":"10.1038\/sj.neo.7900263"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_022","doi-asserted-by":"crossref","unstructured":"Zuo PY, Chen XL, Liu YW, Xiao CL, Liu CY. Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis. PloS One, 2014; 9: e102484.","DOI":"10.1371\/journal.pone.0102484"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_023","doi-asserted-by":"crossref","unstructured":"Lysov Z, Dwivedi DJ, Gould TJ, Liaw PC. Procoagulant effects of lung cancer chemotherapy: impact on microparticles and cell-free DNA. Blood Coagul Fibrinolysis. 2017; 28:72-82.","DOI":"10.1097\/MBC.0000000000000546"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_024","doi-asserted-by":"crossref","unstructured":"Hung SK, Lee MS, Chiou WY, et al. High incidence of ischemic stroke occurrence in irradiated lung cancer patients: a population-based surgical cohort study. PloS One. 2014; 9:e94377.","DOI":"10.1371\/journal.pone.0094377"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_025","doi-asserted-by":"crossref","unstructured":"Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: Burden, mechanisms, and management. Thromb Haemost. 2017;117(2):219-230.","DOI":"10.1160\/TH16-08-0615"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_026","doi-asserted-by":"crossref","unstructured":"Falanga A, Alessio MG, Donati MB, Barbui T. A new procoagulant in acute leukemia. Blood 1988; 71: 870\u2013875.","DOI":"10.1182\/blood.V71.4.870.bloodjournal714870"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_027","doi-asserted-by":"crossref","unstructured":"Kazmierczak M, Lewandowski K, Wojtukiewicz MZ, et al. Cancer procoagulant in patients with adenocarcinomas. Blood Coagul Fibrinolysis 2005; 16: 543\u2013547.","DOI":"10.1097\/01.mbc.0000188413.32859.b2"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_028","doi-asserted-by":"crossref","unstructured":"Ueno T, Toi M, Koike M, Nakamura S, Tominaga T. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer. 2000; 83: 164\u2013170.","DOI":"10.1054\/bjoc.2000.1272"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_029","doi-asserted-by":"crossref","unstructured":"Uno K, Homma S, Satohet T, et al. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer. 2007; 96: 290\u2013295.","DOI":"10.1038\/sj.bjc.6603552"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_030","doi-asserted-by":"crossref","unstructured":"Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50\u2013 to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007; 97: 425\u2013434.","DOI":"10.1160\/TH06-06-0313"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_031","doi-asserted-by":"crossref","unstructured":"Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008; 8: 887\u2013899.","DOI":"10.1038\/nrc2507"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_032","doi-asserted-by":"crossref","unstructured":"Kirchhofer D, Tschopp TB, Hadv\u00e1ry P, Baumgartner HR. Endothelial cells stimulated with tumor necrosis factoralpha express varying amounts of tissue factor resulting in homogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest. 1994; 93: 2073\u2013 2083.","DOI":"10.1172\/JCI117202"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_033","doi-asserted-by":"crossref","unstructured":"Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res. 2005; 96: 1233\u20131239.","DOI":"10.1161\/01.RES.0000171805.24799.fa"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_034","doi-asserted-by":"crossref","unstructured":"Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers underflow. Blood. 2004; 104: 100\u2013106.","DOI":"10.1182\/blood-2004-01-0107"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_035","doi-asserted-by":"crossref","unstructured":"Fuchs TA, Brill A, Wagner DD. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol 2012; 32: 1777\u20131783.","DOI":"10.1161\/ATVBAHA.111.242859"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_036","doi-asserted-by":"crossref","unstructured":"Binder BR, Christ G, Gruber F, et al. Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci. 2002; 17: 56\u201361.","DOI":"10.1152\/nips.01369.2001"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_037","doi-asserted-by":"crossref","unstructured":"Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a review. Acta Neurol Scand.2009;119:1-16.","DOI":"10.1111\/j.1600-0404.2008.01059.x"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_038","doi-asserted-by":"crossref","unstructured":"Zhang YY, Cordato D, Shen Q, Sheng AZ, Hung WT, Chan DK. Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study. Cerebrovasc Dis.2007;23:181-87.","DOI":"10.1159\/000097639"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_039","doi-asserted-by":"crossref","unstructured":"Stefan O, Vera N, Otto B, Heinz L, Wolfgang G. Stroke in cancer patients: a risk factor analysis. J Neurooncol.2009;94:221-26.","DOI":"10.1007\/s11060-009-9818-3"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_040","doi-asserted-by":"crossref","unstructured":"Katsiari CG, Bogdanos DP, Sakkas LI. Inflammation and cardiovascular disease. World J Transl Med. 2019; 8(1): 1-8.","DOI":"10.5528\/wjtm.v8.i1.1"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_041","doi-asserted-by":"crossref","unstructured":"Kim K, Lee J-H. Risk factors and biomarkers of ischemic stroke in cancer patients. J Stroke.2014;16:91-6.","DOI":"10.5853\/jos.2014.16.2.91"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_042","doi-asserted-by":"crossref","unstructured":"Nguyen T, DeAngelis LM. Stroke in cancer patients. Curr Neurol Neurosci Rep.2006;6:187-92.","DOI":"10.1007\/s11910-006-0004-0"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_043","doi-asserted-by":"crossref","unstructured":"Kim SG, Hong JM, Kim HY, et al. Ischemic stroke cancer in patients with and without conventional mechanism. Stroke. 2010;41:798-801.","DOI":"10.1161\/STROKEAHA.109.571356"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_044","doi-asserted-by":"crossref","unstructured":"Alvarez-Perez FJ, Castelo-Branco M, Alvarez-Sabin J. Usefulness of measurement of fibrinogen, D-dimer, D-dimer\/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischemic stroke. J Neurol Neurosurg Psychiatry.2011;82:986-92.","DOI":"10.1136\/jnnp.2010.230870"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_045","doi-asserted-by":"crossref","unstructured":"Aarnio K, Joensuu H, Haapaniemi E, et al. Cancer in young adults with ischemic stroke. Stroke.2015;46:1601-6.","DOI":"10.1161\/STROKEAHA.115.008694"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_046","doi-asserted-by":"crossref","unstructured":"Chen PC, Muo CH, Lee YT, Yu YH, Sung FC. Lung cancer and incidence of stroke: a population-based cohort study. Stroke.2011;42:3034-39.","DOI":"10.1161\/STROKEAHA.111.615534"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_047","doi-asserted-by":"crossref","unstructured":"Bick RL. Cancer-associated thrombosis. N Engl J Med.2003;349:109-11.","DOI":"10.1056\/NEJMp030086"},{"key":"2024043016334229728_j_jccm-2021-0002_ref_048","doi-asserted-by":"crossref","unstructured":"Cutting S, Wettengel M, Conners JJ, Ouyang B, Busl K. Three-months outcomes are poor in stroke patients with cancer despite acute stroke treatment. J Stroke Cerebrovasc Dis. 2017;26:809-15.","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.10.021"}],"container-title":["The Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciendo.com\/pdf\/10.2478\/jccm-2021-0002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T20:49:20Z","timestamp":1714510160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciendo.com\/article\/10.2478\/jccm-2021-0002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,29]]},"published-print":{"date-parts":[[2021,1,29]]}},"alternative-id":["10.2478\/jccm-2021-0002"],"URL":"https:\/\/doi.org\/10.2478\/jccm-2021-0002","relation":{},"ISSN":["2393-1817"],"issn-type":[{"value":"2393-1817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}